Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of CHF1535 50/6 NEXThaler vs Free Combination in Asthmatic Children
NCT01658891Phase 3Withdrawn
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Feb 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate and formoterol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Lower Leg Growth rate measured by Knemometry at 2 weeks. Planned start Feb 2014; status: withdrawn.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01658891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01658891.